Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Ru-Hong Tu is a leading surgical oncologist whose research centers on the application of robotic and minimally invasive techniques for gastric cancer treatment. His major contributions lie in rigorously comparing robotic versus laparoscopic gastrectomy through high-quality clinical trials and propensity score-matched studies. Notably, his landmark 2020 randomized controlled trial (236 citations) provided the first robust evidence that robotic distal gastrectomy offers comparable safety and efficacy to laparoscopy, while his 2024 phase 2 trial (42 citations) further advanced the field by evaluating survival outcomes. Dr. Tu has also pioneered specialized procedures, such as robotic spleen-preserving total gastrectomy and Huang’s three-step maneuver for splenic hilar lymphadenectomy, demonstrating superior short-term advantages. His work consistently examines oncological outcomes, cost, and surgical stress, with multiple studies accumulating over 40 citations each. By systematically addressing the technical and clinical nuances of robotic surgery, Dr. Tu has helped define best practices for advanced gastric cancer, making him a key figure in the evolution of minimally invasive surgical oncology.